Evidence map›Paper›PMID 40213189›Full record

ReviewAnnals of medicine and surgery (2012)2025

The safety of indocyanine green in patients with advanced chronic kidney disease or kidney transplantation: a scoping review.

Mo W Kruiswijk, Ha Lan Nguyen Dinh, Floris P Tange, Stefan Koning, Pim van den Hoven, Roderick C Peul, Joris I Rotmans, Volkert A L Huurman, Ian P J Alwayn, Jaap F Hamming and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mo W KruiswijkDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Ha Lan Nguyen DinhDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Floris P TangeDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Stefan KoningDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Pim van den HovenDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Roderick C PeulDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Joris I RotmansDepartment of Internal Medicine, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Volkert A L HuurmanDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Ian P J AlwaynDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Jaap F HammingDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Alexander L VahrmeijerDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.
Joost R van der VorstDepartment of Surgery, Leiden University Medical Center, Albinusdreef, ZA, Leiden, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Near-infrared fluorescence imaging with indocyanine green (ICG) is increasingly being used in the field of image-guided surgery. Although ICG is considered non-nephrotoxic in current literature, caution is advised for the use of ICG in patients with advanced chronic kidney disease (CKD), including kidney transplant recipients. Therefore, a scoping review was performed to assess the safety of ICG in patients with advanced CKD or a renal allograft. This scoping review was guided by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews). Web of Science, PubMed, and Embase were searched for articles and abstracts in which ICG was administered in patients with CKD or a renal allograft. The extracted data included the incidence of adverse events, kidney function after injection of ICG, preservation of transplant function, and type of other possible complications. The initial search resulted in 635 records of which 19 studies were found eligible for the review. ICG was used for multiple purposes but never specifically as an objective to investigate possible nephrotoxicity. No adverse events were reported in the transplant group (

Indexed as

chronic kidney diseasefluorescent dyesindocyanine greenkidney transplantationnear-infrared fluorescence imaging

Identifiers

PMID40213189
PMCPMC11981315

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.